In an effort to identify the downstream mechanisms by which PDGF induces bone cancer pain, we used WB to evaluate the activation (phosphorylation) of PDGFR, ERK and AKT by measuring levels of pPDGFRα/β, pERK and pAKT 14 days after treatment with PDGF siRNA. Here, AKT1 is linked to bone cancer.